The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial

Title
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
Authors
Keywords
Necitumumab, Health-related quality of life, Lung Cancer Symptom Scale, EQ-5D, Tolerability
Journal
Journal of Thoracic Oncology
Volume 11, Issue 6, Pages 808-818
Publisher
Elsevier BV
Online
2016-03-13
DOI
10.1016/j.jtho.2016.03.002

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started